תקציר
QUESTION: One of my patients who was taking sibutramine to lose weight found out that she had unexpectedly conceived. The medication was stopped as soon as she found out, about 5 weeks into the pregnancy. Is the baby at risk? Should the pregnancy be aborted? ANSWER: No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations. Nevertheless, this medication should be avoided whenever possible during pregnancy, as there is little information on its effects.
| שפה מקורית | אנגלית |
|---|---|
| עמודים (מ-עד) | 229-230 |
| מספר עמודים | 2 |
| כתב עת | Canadian Family Physician |
| כרך | 53 |
| מספר גיליון | 2 |
| סטטוס פרסום | פורסם - פבר׳ 2007 |
טביעת אצבע
להלן מוצגים תחומי המחקר של הפרסום 'Exposure to sibutramine during pregnancy'. יחד הם יוצרים טביעת אצבע ייחודית.פורמט ציטוט ביבליוגרפי
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver